Abstract
Monogenic autoinflammatory syndromes (MAISs), are caused by pathogenic genetic variants in the innate immune system, leading to dysregulation and aberrant inflammasome activation spontaneously or with minimal triggering. The diagnosis and treatment of MAISs can be intricate, relying on an increased recognition of potential differential diagnoses. This review examines the clinical features of MAIS, with a special focus on uveitis. It also evaluates treatment options and assesses the effects of activating molecular and cytokine pathways.
| Original language | English |
|---|---|
| Pages (from-to) | 1930-1943 |
| Number of pages | 14 |
| Journal | Ocular Immunology and Inflammation |
| Volume | 31 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 5 Dec 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.